2021 GA Meeting May 12th, 14:00-15:30

2020 GA MEETING

 

The 2020 GA meeting which normally takes place in May was postponed to November 4th due to the global pandemic. The November 4th meeting which was virtual saw 20 attendees and lasted an hour as most of the GA mandated task/decisions were addressed by way of votes prior to the meeting. Chaired by Interim Chairman Dr Bernd Friede, the meeting though brief was effective with some key decisions taken as follows:

Some highlights:

  • Executive Committee: A new Executive team was endorsed with the 2nd Vice-Chairman becoming the Chairman and Secretary General maintained to ensure continuity
  • Non-EU letter of Access Fees: Letter of Access fees and administration fees for non-EU REACH-Like regulations per substance, per legal entity for non-MARA members was established
  • Members involvement in Non-EU regulations: MARA members wishing to register substances in non-EU REACH-like regulations will only pay administration fees as they own the data generated by MARA
  • Technical update: Three dossiers updated this year lead to a new classification for manganese based UVCB’s
  • 2020 Workplan and budget were ratified in Q1, 2020 via round robin votes.

Manganese dichloride (EC: 231-869-6; Cas: 7773-01-5)

Submitted in 2010, with no testing proposals, this substance has not undergone any aspect of the REACH evaluation process to date.

However, because of its solubility and bioavailability, this substance is often the test material choice for most academic studies which end up being published in peer-review literature. The outcome of these publications can change the hazard assessment of the dossier. Hence, Literature review is carried every two years. Furthermore, new information on two reproductive endpoints (two generation reproductive toxicity and pre-natal developmental toxicity) are available from the International Manganese Institute (IMnI) worker safety program. Both studies used MnCl2 as the test material. Therefore, the information from the published literature and from those studies developed by the IMnI triggered a spontaneous dossier update. 

The dossier was submitted earlier this year (2019) with new available data, in alignment with post 2010 ECHA guidance documents and the post 2010 CLP adaptations requirements. All co-registrants that had met their financial obligations were provided with the following:

1) Updated CSR

2) Exposure scenarios for their eSDS

3) Updated CLP classification.

An SDS temeplate has been prepared (Q3, 2019) for industry's use. This can be provided to you upon request - contact reach@manganese.org

Note: Post 2018, the consortium will no longer invoice co-registrants  for ECHA requested studies retrospectively. All compliance check related work will require co-registrants to contribute their share before any dossier update work can begin. 

« Back to news


About cookies on our website

Following a revised EU directive on website cookies, each company based, or doing business, in the EU is required to notify users about the cookies used on their website.

Our site uses cookies to improve your experience of certain areas of the site and to allow the use of specific functionality like social media page sharing. You may delete and block all cookies from this site, but as a result parts of the site may not work as intended.

To find out more about what cookies are, which cookies we use on this website and how to delete and block cookies, please see our Which cookies we use page.

Click on the button below to accept the use of cookies on this website (this will prevent the dialogue box from appearing on future visits)